サマリー

性感染症（STD）治療の世界市場 2022-2026 年
Technavioは性感染症（STD）治療市場を監視しており、2022-2026年の間に134億8000万ドルの成長が見込まれ、予測期間中にCAGR4.27％で加速しています。当レポートでは、性感染症（STD）治療市場の全体分析、市場規模・予測、トレンド、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、STDの有病率の増加、有利な保険償還政策の存在、世界各国の政府による取り組みの活発化によって牽引されています。
性感染症（STD）治療市場の分析には、タイプ別セグメントと地域別の展望が含まれます。
Technavioの性感染症（STD）治療市場は、以下のように区分されています。
タイプ別
- ウイルス感染症
- 細菌感染症
- その他の感染症
地域別状況
- 北アメリカ
- 欧州
- アジア
- その他の地域（ROW）
本調査では、今後数年間の性感染症（STD）治療市場の成長を牽引する主要な理由の一つとして、STDの迅速な診断の進歩を挙げています。また、STDと迅速パートナー療法（EPT）についての意識を高めるための様々な組織の関与の増加は、市場の大きな需要につながるでしょう。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。性感染症（STD）治療市場に関する当レポートの対象領域は以下の通りです。
- 性感染症（STD）治療市場のサイジング
- 性感染症（STD）治療市場の予測
- 性感染症（STD）治療市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、性感染症（STD）治療市場の主要ベンダー数社に関する詳細な分析を提供しています。KG、セファイド社、DiaSorin SpA、ダイナバックス・テクノロジー社、F. Hoffmann La Roche Ltd.、ギリアド・サイエンス社、グラクソ・スミスクライン社、Hologic社、Inovio Pharmaceuticals Inc.、Johnson and Johnson、リーズファーマスーティカル・ホールディングス社、Lupin Ltd.、Merck and Co.Inc.、Mylan N.V.、Pfizer Inc.が含まれています。また、性感染症（STD）治療市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/sexually-transmitted-diseases-std-treatment-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Viral infections - Market size and forecast 2021-2026
o Exhibit 28: Chart on Viral infections - Market size and forecast 2021-2026 ($ billion)
o Exhibit 29: Data Table on Viral infections - Market size and forecast 2021-2026 ($ billion)
o Exhibit 30: Chart on Viral infections - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Viral infections - Year-over-year growth 2021-2026 (%)
o 5.4 Bacterial infections - Market size and forecast 2021-2026
o Exhibit 32: Chart on Bacterial infections - Market size and forecast 2021-2026 ($ billion)
o Exhibit 33: Data Table on Bacterial infections - Market size and forecast 2021-2026 ($ billion)
o Exhibit 34: Chart on Bacterial infections - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Bacterial infections - Year-over-year growth 2021-2026 (%)
o 5.5 Other infections - Market size and forecast 2021-2026
o Exhibit 36: Chart on Other infections - Market size and forecast 2021-2026 ($ billion)
o Exhibit 37: Data Table on Other infections - Market size and forecast 2021-2026 ($ billion)
o Exhibit 38: Chart on Other infections - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Other infections - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Type
o Exhibit 40: Market opportunity by Type ($ billion)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ billion)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
o Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
o Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ billion)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ billion)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Japan - Market size and forecast 2021-2026
o Exhibit 66: Chart on Japan - Market size and forecast 2021-2026 ($ billion)
o Exhibit 67: Data Table on Japan - Market size and forecast 2021-2026 ($ billion)
o Exhibit 68: Chart on Japan - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Japan - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ billion)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ billion)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 Germany - Market size and forecast 2021-2026
o Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
o Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
o Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.11 UK - Market size and forecast 2021-2026
o Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ billion)
o Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
o Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ billion)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 89: AbbVie Inc. - Overview
o Exhibit 90: AbbVie Inc. - Product / Service
o Exhibit 91: AbbVie Inc. - Key offerings
o 10.4 Aurobindo Pharma Ltd.
o Exhibit 92: Aurobindo Pharma Ltd. - Overview
o Exhibit 93: Aurobindo Pharma Ltd. - Product / Service
o Exhibit 94: Aurobindo Pharma Ltd. - Key offerings
o 10.5 Bristol Myers Squibb Co.
o Exhibit 95: Bristol Myers Squibb Co. - Overview
o Exhibit 96: Bristol Myers Squibb Co. - Product / Service
o Exhibit 97: Bristol Myers Squibb Co. - Key offerings
o 10.6 C. H. Boehringer Sohn AG and Co. KG
o Exhibit 98: C. H. Boehringer Sohn AG and Co. KG - Overview
o Exhibit 99: C. H. Boehringer Sohn AG and Co. KG - Business segments
o Exhibit 100: C. H. Boehringer Sohn AG and Co. KG - Key news
o Exhibit 101: C. H. Boehringer Sohn AG and Co. KG - Key offerings
o Exhibit 102: C. H. Boehringer Sohn AG and Co. KG - Segment focus
o 10.7 Dynavax Technologies Corp.
o Exhibit 103: Dynavax Technologies Corp. - Overview
o Exhibit 104: Dynavax Technologies Corp. - Product / Service
o Exhibit 105: Dynavax Technologies Corp. - Key news
o Exhibit 106: Dynavax Technologies Corp. - Key offerings
o 10.8 F. Hoffmann La Roche Ltd.
o Exhibit 107: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 108: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 109: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 110: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 111: F. Hoffmann La Roche Ltd. - Segment focus
o 10.9 Gilead Sciences Inc.
o Exhibit 112: Gilead Sciences Inc. - Overview
o Exhibit 113: Gilead Sciences Inc. - Product / Service
o Exhibit 114: Gilead Sciences Inc. - Key news
o Exhibit 115: Gilead Sciences Inc. - Key offerings
o 10.10 GlaxoSmithKline Plc
o Exhibit 116: GlaxoSmithKline Plc - Overview
o Exhibit 117: GlaxoSmithKline Plc - Business segments
o Exhibit 118: GlaxoSmithKline Plc - Key news
o Exhibit 119: GlaxoSmithKline Plc - Key offerings
o Exhibit 120: GlaxoSmithKline Plc - Segment focus
o 10.11 Johnson and Johnson
o Exhibit 121: Johnson and Johnson - Overview
o Exhibit 122: Johnson and Johnson - Business segments
o Exhibit 123: Johnson and Johnson - Key news
o Exhibit 124: Johnson and Johnson - Key offerings
o Exhibit 125: Johnson and Johnson - Segment focus
o 10.12 Merck and Co. Inc.
o Exhibit 126: Merck and Co. Inc. - Overview
o Exhibit 127: Merck and Co. Inc. - Business segments
o Exhibit 128: Merck and Co. Inc. - Key news
o Exhibit 129: Merck and Co. Inc. - Key offerings
o Exhibit 130: Merck and Co. Inc. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 131: Inclusions checklist
o Exhibit 132: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 133: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 134: Research methodology
o Exhibit 135: Validation techniques employed for market sizing
o Exhibit 136: Information sources
o 11.5 List of abbreviations
o Exhibit 137: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Viral infections - Market size and forecast 2021-2026 ($ billion)
Exhibits29: Data Table on Viral infections - Market size and forecast 2021-2026 ($ billion)
Exhibits30: Chart on Viral infections - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Viral infections - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Bacterial infections - Market size and forecast 2021-2026 ($ billion)
Exhibits33: Data Table on Bacterial infections - Market size and forecast 2021-2026 ($ billion)
Exhibits34: Chart on Bacterial infections - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Bacterial infections - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Other infections - Market size and forecast 2021-2026 ($ billion)
Exhibits37: Data Table on Other infections - Market size and forecast 2021-2026 ($ billion)
Exhibits38: Chart on Other infections - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Other infections - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Type ($ billion)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ billion)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ billion)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Japan - Market size and forecast 2021-2026 ($ billion)
Exhibits67: Data Table on Japan - Market size and forecast 2021-2026 ($ billion)
Exhibits68: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ billion)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ billion)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibits75: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibits76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits79: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ billion)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: AbbVie Inc. - Overview
Exhibits90: AbbVie Inc. - Product / Service
Exhibits91: AbbVie Inc. - Key offerings
Exhibits92: Aurobindo Pharma Ltd. - Overview
Exhibits93: Aurobindo Pharma Ltd. - Product / Service
Exhibits94: Aurobindo Pharma Ltd. - Key offerings
Exhibits95: Bristol Myers Squibb Co. - Overview
Exhibits96: Bristol Myers Squibb Co. - Product / Service
Exhibits97: Bristol Myers Squibb Co. - Key offerings
Exhibits98: C. H. Boehringer Sohn AG and Co. KG - Overview
Exhibits99: C. H. Boehringer Sohn AG and Co. KG - Business segments
Exhibits100: C. H. Boehringer Sohn AG and Co. KG - Key news
Exhibits101: C. H. Boehringer Sohn AG and Co. KG - Key offerings
Exhibits102: C. H. Boehringer Sohn AG and Co. KG - Segment focus
Exhibits103: Dynavax Technologies Corp. - Overview
Exhibits104: Dynavax Technologies Corp. - Product / Service
Exhibits105: Dynavax Technologies Corp. - Key news
Exhibits106: Dynavax Technologies Corp. - Key offerings
Exhibits107: F. Hoffmann La Roche Ltd. - Overview
Exhibits108: F. Hoffmann La Roche Ltd. - Business segments
Exhibits109: F. Hoffmann La Roche Ltd. - Key news
Exhibits110: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits111: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits112: Gilead Sciences Inc. - Overview
Exhibits113: Gilead Sciences Inc. - Product / Service
Exhibits114: Gilead Sciences Inc. - Key news
Exhibits115: Gilead Sciences Inc. - Key offerings
Exhibits116: GlaxoSmithKline Plc - Overview
Exhibits117: GlaxoSmithKline Plc - Business segments
Exhibits118: GlaxoSmithKline Plc - Key news
Exhibits119: GlaxoSmithKline Plc - Key offerings
Exhibits120: GlaxoSmithKline Plc - Segment focus
Exhibits121: Johnson and Johnson - Overview
Exhibits122: Johnson and Johnson - Business segments
Exhibits123: Johnson and Johnson - Key news
Exhibits124: Johnson and Johnson - Key offerings
Exhibits125: Johnson and Johnson - Segment focus
Exhibits126: Merck and Co. Inc. - Overview
Exhibits127: Merck and Co. Inc. - Business segments
Exhibits128: Merck and Co. Inc. - Key news
Exhibits129: Merck and Co. Inc. - Key offerings
Exhibits130: Merck and Co. Inc. - Segment focus
Exhibits131: Inclusions checklist
Exhibits132: Exclusions checklist
Exhibits133: Currency conversion rates for US$
Exhibits134: Research methodology
Exhibits135: Validation techniques employed for market sizing
Exhibits136: Information sources
Exhibits137: List of abbreviations